Want to join the conversation?
$VAR, which competes with $ARAY and Siemens Healthcare, said it ended 2Q16 at $3.3Bil of backlog, up 6% from 2Q15. Backlog adjustments during 2Q16 totaled $51MM, bringing net orders for the company to $707MM. For 2H16, total company revenues were up 1% in dollars and up 4% in constant currency.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.